Clinical trial
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
NCT00480896 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00480896 |
|---|---|
| Title | Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment |
| Official title | Clinical Study on Tacrolimus Ointment Over the Long-term. "CONTROL Study - Children" |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dermatitis, Atopic |
| Intervention type | Drug |
| Interventions | tacrolimus ointment, Placebo ointment |
| Enrollment | 250 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | May 31, 2007 |
| Last update posted | Sep 18, 2014 |
| Countries | Belgium, Czechia, Finland, France, Germany, Hungary, Italy, Netherlands, Portugal, Spain, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: